(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 25793.00 | 19768.00 | 30.48 | 87316.00 | 78369.00 | 11.42 | 87316.00 | 78369.00 | 11.42 |
| Other Income | 2512.00 | 537.00 | 367.78 | 5484.00 | 1787.00 | 206.88 | 5484.00 | 1787.00 | 206.88 |
| PBIDT | 10237.00 | 5113.00 | 100.22 | 30028.00 | 20968.00 | 43.21 | 30028.00 | 20968.00 | 43.21 |
| Interest | 850.00 | 420.00 | 102.38 | 2782.00 | 1349.00 | 106.23 | 2782.00 | 1349.00 | 106.23 |
| PBDT | 7349.00 | 4693.00 | 56.59 | 25208.00 | 16426.00 | 53.46 | 25208.00 | 16426.00 | 53.46 |
| Depreciation | 1199.00 | 1228.00 | -2.36 | 4886.00 | 4787.00 | 2.07 | 4886.00 | 4787.00 | 2.07 |
| PBT | 6150.00 | 3465.00 | 77.49 | 20322.00 | 11639.00 | 74.60 | 20322.00 | 11639.00 | 74.60 |
| TAX | 1243.00 | 996.00 | 24.80 | 5030.00 | 3060.00 | 64.38 | 5030.00 | 3060.00 | 64.38 |
| Deferred Tax | -53.00 | 217.00 | -124.42 | 412.00 | 458.00 | -10.04 | 412.00 | 458.00 | -10.04 |
| PAT | 4907.00 | 2469.00 | 98.74 | 15292.00 | 8579.00 | 78.25 | 15292.00 | 8579.00 | 78.25 |
| Equity | 1012.00 | 1024.00 | -1.17 | 1012.00 | 1024.00 | -1.17 | 1012.00 | 1024.00 | -1.17 |
| PBIDTM(%) | 39.69 | 25.87 | 53.45 | 34.39 | 26.76 | 28.53 | 34.39 | 26.76 | 28.53 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.55 |
| Dr. Reddys Lab | 1235.85 |
| Cipla | 1236.15 |
| Zydus Lifesciences | 942.40 |
| Lupin | 2334.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: